Wenshan Zhang

2 articles listing Wenshan Zhang in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO) Nature Communications
2. Author Correction: Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche Nature Communications